The present exemplary embodiment relates to instruments or devices for collecting and sorting particles or samples, particularly from liquid or gaseous media. The exemplary embodiment finds particular application in conjunction with the separation and detection of biological agents, and will be described with particular reference thereto. However, it is to be appreciated that the present exemplary embodiment is also amenable to other like applications.
Bio-agents dispersed either in aerosol form or in water are typically in such low concentrations that they are below the limit of detection (LOD) of even the most sensitive detection schemes. Yet, the ingestion of even a single bacterium may lead to fatal consequences. Accordingly, regardless of whether the sample is derived from aerosol or water collection, there exists a need to further concentrate the sample prior to detection.
Aerosol and hydrosol collection schemes typically sample large volumes of air at very high rates (150 kL/min and up), and use a cyclone-impactor design to collect particles having a size in the threat range and capture them in a wet sample of 5-10 mL volume. This supernatant is then used as the test sample for agent detection. In order to use currently available detection strategies, it would be desirable to further concentrate the hydrosol by another two orders of magnitude. For example, this could be achieved by collecting all the bio-particles in the sample volume within a smaller volume of 50-100 μL.
Contaminants in water are typically treated by several filtration steps to recover the sample for agent testing. After initial pre-filtration to remove larger vegetative matter, the sample is further concentrated by two to three orders of magnitude using ultra-filtration. This method of tangential flow filtration (TFF) is laborious as it may require multiple sequential steps of TFF; each step utilizing a filter of molecular weight (MW) cut-off that is 3-6× lower than the MW of the target molecules, and recycling of the retentate. The limiting factor for TFF is system loss, where there is a cut-off below which it may not provide any further improvement in concentration. The retentate at the end is approximately a 50 mL volume to be presented to the detector. It would be particularly desirable to further concentrate the retentate by up to another three orders of magnitude.
Field Flow Fractionation (FFF) is a technique that allows the separation of particles of different charge to size ratios (q/d) in a flow channel. This technique is useful in many fields ranging from printing to biomedical and biochemical applications. Separation is achieved because particles with different q/d ratios require different times to move across the flow channel, and therefore travel different distances along the flow channel before arriving at a collection wall. To obtain well-defined and separated bands of species with different q/d values, the particles are typically injected through a narrow inlet from the top of the channel. Total throughput depends on the inlet geometry and flow rate, which in turn affects the q/d resolution of the system.
FFF relies upon the presence of a field perpendicular to the direction of separation to control the migration of particles injected into a flow field. The separated components are eluted one at a time out of the system based on retention times, and are collected in a sequential manner. The separations are performed in a low viscosity liquid, typically an aqueous buffer solution, which is pumped through the separation channel and develops a parabolic velocity profile typical of Poissieulle flow. The process depends on controlling the relative velocity of injected particles by adjusting their spacing from the side walls. Particles with higher electrophoretic mobility or zeta potential will pack closer to the walls and therefore move slower than those that are nearer the center of the channel. In effect, particles move at different rates through the system based on zeta potential and size. Use of different separation mechanisms such as thermal, magnetic, dielectrophoretic, centrifugation, sedimentation, steric, and orthogonal flow has given rise to a family of FFF methods. Although satisfactory in many respects, there remains a need for an improved FFF separation technique.
The present exemplary embodiment contemplates a new and improved system, device, cells, and related methods which overcome the above-referenced problems and others.
U.S. Pat. Nos. 6,351,623; 6,290,342; 6,272,296; 6,246,855; 6,219,515; 6,137,979; 6,134,412; 5,893,015; and 4,896,174, all of which are hereby incorporated by reference.
In a first aspect, the exemplary embodiment provides a traveling wave grid system comprising a first traveling wave grid, a second traveling wave grid downstream of the first wave grid, and a transition region extending between the first and second traveling wave grids. The transition region includes a collection of arcuate traces. The transition region is adapted to transport and cause convergence of a particle stream from the first grid to the second grid.
In another aspect, the exemplary embodiment provides a method for differentiating and optionally collecting particles according to size from a sample of particles. The method comprises providing a traveling wave grid system including a first traveling wave grid and a second traveling wave grid. The first and second traveling wave grids are oriented at an angle with respect to each other. The angle ranges from about 10° to about 170°. The method comprises introducing a sample containing particles of different sizes onto the first traveling wave grid. The method further comprises operating the traveling wave grid system to thereby transport the particles along the first and second traveling wave grids. Upon undergoing a change in direction corresponding to the angled orientation of the first and second traveling wave grids, the particles separate into at least two groups according to size of the particles.
In yet a further aspect, the exemplary embodiment provides a method for differentiating and optionally collecting particles according to size from a sample of particles. The method comprises providing a traveling wave grid including a provision for selectively adjusting a sweep frequency of an electrical voltage signal applied to the grid. The method also comprises introducing a sample containing particles of different sizes on the traveling wave grid. The method further comprises operating the grid at a first sweep frequency whereby particles of a first size are displaced from one region of the grid to another. And, the method comprises, operating the grid at a second sweep frequency different than the first sweep frequency whereby particles of a second size, different than the first size, are displaced from one region of the grid to another.
In a further aspect, the exemplary embodiment provides a purification cell adapted to remove and classify particles from a sample. The cell comprises a concentration chamber including a first traveling wave grid, a separation chamber including a second traveling wave grid, and a focusing channel extending between the first and second traveling wave grids. The focusing channel includes a third traveling wave grid. The second and third traveling wave grids are oriented at an angle of from about 10° to about 170° with respect to each other. The separation chamber further includes a collection of compartments adapted to receive particles of different sizes. The collection of compartments are aligned across the second traveling wave grid.
Currently there are no other effective methods to concentrate very dilume amounts of bio agents (or bio molecules) in a liquid sample beyond the typical concentrations achieved by centrifugation and ultrafiltration. Centrifugation at high speed (10,000 rpm) may be used to pellet out large numbers of particles such as bacteria; however, it is not readily portable. The exemplary embodiment device is able to process the retentate after ultrafiltration and provide further concentration by a factor of a hundred or greater. In addition, few devices are available that can handle the volume typically associated with purification or bio-enrichment operations. Lab-on-chip (LOC) devices may handle only minute volumes. The exemplary embodiment device can readily handle such large volumes
More specifically, the exemplary embodiment provides various unique traveling wave array configurations that can be utilized to optimize device operation and specifically, to maximize mass transport and to minimize congestion. The exemplary embodiment also provides various methods for sample separation in a liquid medium. And, the exemplary embodiment provides purification cells utilizing cascaded traveling wave grids that provide functions of concentration, focusing, and separation.
The term “traveling wave grid” or “traveling wave array” as used herein, collectively refers to a substrate, a plurality of electrodes to which a voltage waveform is applied to generate the traveling wave(s), and one or more busses, vias, and electrical contact pads to distribute the electrical signals (or voltage potentials) throughout the grid. The term also collectively refers to one or more sources of electrical power, which provides the multi-phase electrical signal for operating the grid. The traveling wave grids may be in nearly any form, such as for example a flat planar form, or a non-planar form. The non-planar form can be, for example, in the form of an arcuate region extending along the outer wall of a cylinder. The non-planar grid could be in the form of an annular grid defined within an interior region of a tube. Traveling wave grids, their use, and manufacture are generally described in the previously noted U.S. patents.
As referred to herein, the various exemplary embodiment traveling wave grid systems comprise one or more chevron grids. The term “chevron” as used herein refers to a pattern of electrodes or traces constituting the traveling wave grid or portion thereof, in which a significant portion of the traces, and typically all traces, are arcuate and also arranged in a concentric fashion. Typically, the arcuate traces are also arranged such that they are defined about one or more center points that are located upstream from the intended direction of particle flow during operation of the collection of traces. This configuration, relative to the direction of flow, serves to maintain direction of the stream and reduce dispersion of particulates in the flowing stream.
Another aspect of the traveling wave grid or array system described herein is that the grids are in certain applications, oriented at some angle with respect to each other. This orientation aspect is actually with regard to the intended (or actual) direction of travel of particulates on one grid relative to the direction of travel of particulates on another grid. Generally, the angle between adjacent grids or regions of grids can be from about 10° to about 170°, more particularly from about 45° to about 135°, and often about 90°. In certain applications, the exemplary embodiment utilizes the directional change of particle flow streams to differentiate, separate, and/or classify the particles.
A traveling wave array can comprise adjacent rectilinear and chevron grids 10 and 50, respectively as shown in
To mitigate against this condition and to increase the mass flow rate (which would be useful for biomedical applications where higher concentrations would be involved), the exemplary embodiment provides several versions of improved systems of traveling wave grids. Generally, in accordance with the exemplary embodiment, a system of traveling wave grids or arrays is provided that comprise a first traveling wave grid which is typically in the form of a rectilinear grid, a second traveling wave grid, which can be in the form of either a rectilinear grid or a chevron grid, or some other type of grid, and a transition region extending between the first and second grids. As noted, the first and second grids are oriented at an angle with respect to each other. The transition region is a traveling wave grid, or portion thereof, which serves to efficiently assist in transporting particulates from one grid to another, and preferably also promotes the change in direction of the particulates.
Specifically,
In
The exemplary embodiment also provides strategies for particle separation. Most particulates have a native charge dependent on pH which leads to a Coulomb force, but may also polarize in a non-uniform field. The induced dipole moment (Clausius-Mossofti) is:
p=4πa3∈o(∈−1)/(∈+2)E; ∈=∈particle/∈fluid
where a is the particle radius, ∈particle is the particle dielectric constant, and ∈fluid is the fluid dielectric constant. For low frequencies, ∈ is real. The dipole force is given by:
Fdipole=(p·∇)E
Experiments on both Bacillus thuringiensis spores and polystyrene beads in the 200 nm to 10 μm size range show that electro-kinetic transport is a balance of electro-osmotic flow (EOF), electrophoresis, and dielectrophoresis effects.
In one aspect, the exemplary embodiment separates particles by varying the traveling wave sweep frequency. The characteristic transport of traveling waves is synchronous below a threshold sweep frequency and an asynchronous mode above that. The distinction is the balance of Coulomb and dielectrophoretic forces against drag whereby some particles are able to keep up and others are not. This trait is retained for a fluidic environment, especially for larger and more dipolar particles. A sample mixture of 1 μm, 3 μm, and 6 μm polystyrene beads demonstrates that at 3 Hz, all beads in the size range are transported. At 4 Hz, some larger beads are stagnated by being trapped at traces. The reason is that their displacement is shorter than the pitch of the traveling wave array so that they are trapped in a situation where they move back and forth between the traces. At 6 Hz, all beads are trapped. This frequency sensitivity may be exploited in a separation method. The strategy is to scan down in frequency to selectively move the more mobile particles out of the mixture in sequential fashion.
In another aspect, the exemplary embodiment separates particles by bending or turning a particle stream around a corner. Specifically, this mode of separation involves moving the particle stream around a corner where the traveling wave grids transition such that the fields also reflect a change in direction. This strategy is motivated by the observation that when particles of various sizes concentrate into a sample well, they appear to have different turning radii depending on their relative size.
Referring to
The exemplary embodiment also provides a purification cell. The combination of the noted traveling wave grid layouts and sample separation strategies may be incorporated together with the concentration and focusing aspects of the device to provide a purification cell 600 as shown in
For large sample volumes, the exemplary embodiment purification cell may be incorporated into the mFFF cell geometry as shown in
The various purification cells of the exemplary embodiment can employ cascaded functions of concentration, focusing, and separation. The cells can feature a constant volume design, a flow-through configuration with increasing volume, or utilize a constant volume with a recirculating transport to achieve higher purity concentrations.
The advantages of the exemplary embodiment include but are not limited to new traveling wave grid configurations to increase mass flow and to minimize congestion and stagnation; the provision of new strategies for separation; and the provision of a purification cell which can handle tens of milliliters as compared to existing methods which are complicated and only handle up to several hundred microliters.
Potential applications of the exemplary embodiment include but are not limited to pre-concentrators for front-end detection in bio-defense applications; water supply monitoring for utilities; food toxicology; blood plasma separation; cell enrichment; and protein purification.
It will be appreciated that various of the above-disclosed and other features and functions, or alternatives thereof, may be desirably combined into many other different systems or applications. Also that various presently unforeseen or unanticipated alternatives, modifications, variations or improvements therein may be subsequently made by those skilled in the art which are also intended to be encompassed by the following claims.
This invention was made with Government support under W911NF-05-C-0075 awarded by the U.S. Army. The Government has certain rights in this invention.
Number | Name | Date | Kind |
---|---|---|---|
3449938 | Giddings | Jun 1969 | A |
4147621 | Giddings | Apr 1979 | A |
4214981 | Giddings | Jul 1980 | A |
4250026 | Giddings et al. | Feb 1981 | A |
4440638 | Judy et al. | Apr 1984 | A |
4527884 | Nusser | Jul 1985 | A |
4558941 | Nosaki et al. | Dec 1985 | A |
4647179 | Schmidlin | Mar 1987 | A |
4896174 | Stearns | Jan 1990 | A |
5039426 | Giddings | Aug 1991 | A |
5133844 | Stevens | Jul 1992 | A |
5156039 | Giddings | Oct 1992 | A |
5160625 | Jonsson et al. | Nov 1992 | A |
5281982 | Mosehauer et al. | Jan 1994 | A |
5400062 | Salmon | Mar 1995 | A |
5454945 | Spearman | Oct 1995 | A |
5632957 | Heller et al. | May 1997 | A |
5717986 | Vo et al. | Feb 1998 | A |
5850587 | Schmidlin | Dec 1998 | A |
5893015 | Mojarradi et al. | Apr 1999 | A |
6070036 | Thompson et al. | May 2000 | A |
6112044 | Thompson et al. | Aug 2000 | A |
6116718 | Peeters et al. | Sep 2000 | A |
6134412 | Thompson | Oct 2000 | A |
6136171 | Frazier et al. | Oct 2000 | A |
6137979 | Garstein et al. | Oct 2000 | A |
6180956 | Chondroudis et al. | Jan 2001 | B1 |
6192764 | Jiang et al. | Feb 2001 | B1 |
6219515 | Lestrange | Apr 2001 | B1 |
6246855 | Gartstein et al. | Jun 2001 | B1 |
6272296 | Gartstein | Aug 2001 | B1 |
6287832 | Becker et al. | Sep 2001 | B1 |
6290342 | Vo et al. | Sep 2001 | B1 |
6293659 | Floyd et al. | Sep 2001 | B1 |
6328409 | Peeters et al. | Dec 2001 | B1 |
6340216 | Peeters et al. | Jan 2002 | B1 |
6351623 | Thayer et al. | Feb 2002 | B1 |
6355491 | Zhou et al. | Mar 2002 | B1 |
6416158 | Floyd et al. | Jul 2002 | B1 |
6416159 | Floyd et al. | Jul 2002 | B1 |
6439711 | Carlini et al. | Aug 2002 | B1 |
6454384 | Peeters et al. | Sep 2002 | B1 |
6467862 | Peeters et al. | Oct 2002 | B1 |
6467871 | Moffat et al. | Oct 2002 | B1 |
6499831 | Schmidlin | Dec 2002 | B2 |
6511149 | Peeters et al. | Jan 2003 | B1 |
6521297 | McDougall et al. | Feb 2003 | B2 |
6523928 | Peeters et al. | Feb 2003 | B2 |
6598954 | Moffat et al. | Jul 2003 | B1 |
6692627 | Russell et al. | Feb 2004 | B1 |
6719399 | Moffat et al. | Apr 2004 | B2 |
6751865 | Peeters et al. | Jun 2004 | B1 |
7156970 | Lean et al. | Jan 2007 | B2 |
7309410 | Lean et al. | Dec 2007 | B2 |
7374603 | Biegelsen | May 2008 | B2 |
20040000519 | Jiang et al. | Jan 2004 | A1 |
20050247564 | Volkel et al. | Nov 2005 | A1 |
20070057748 | Lean et al. | Mar 2007 | A1 |
20070175801 | Lean et al. | Aug 2007 | A1 |
Number | Date | Country | |
---|---|---|---|
20070057748 A1 | Mar 2007 | US |